News

This is the first patent awarded to the company for skin lightening technology. The company’s patented technology uses small molecule inhibitors to regulate a key enzyme within skin

These potential drug targets were identified using Novo’s proprietary computer model of the ghrelin receptor and already have shown good in vivo proof-of-concept data, according to Sapphire. William

The purpose of the preclinical study was to examine the structural and functional aspects of bladder regeneration in a well-established preclinical model. Tengion’s Neo-Bladder Augment composed of a

Comprised of the Pap-Map Cervical Cancer Collector, the Pap-Map Handle and the Transfer Station, the system allows the clinician to painlessly capture 360 degrees of cervical material and

Clinical research has shown that medical food Corvalen (D-ribose) provides metabolic support to accelerate cellular energy recovery and normal cellular functioning for patients with chronic fatigue syndrome and

The proposed new facility, expected to be operational by 2012, is expected to be Novartis’s biggest investment in its manufacturing capacity. A $180 million plant that manufactures Novartis

The four vaccine products are: measles, mumps and rubella vaccine (MMR), human diploid rabies vaccine, recombinant hepatitis B vaccine and oncology bladder cancer vaccine (BCG). Serum is presently

In Spain, Laboratorios Davur, as well as two other Bentley subsidiaries, Laboratorios Rimafar and Laboratorios Belmac, received approval for alendronate weekly for osteoporosis and bone loss, the generic

The patent at issue in the lawsuit expires in July 2010. The decision, which resulted from a patent challenge by generic manufacturers Ranbaxy Laboratories Limited and its subsidiary